This past September, my colleague and I published a paper in the journal eLife on inequalities in the support of scientists designated as Principal Investigators (PIs) of NIH Research Project Grant (RPG) awards. We found that funding inequality among PIs has increased over the past 25 years, but may have decreased modestly in more recent years. We also found greater levels of inequality across organizations.
As the snow fell outside last week, I virtually sat down with Dr. David Kosub from the NIH Office of Extramural Research’s communications group to look back and reflect on 2021, and where we may be going in the new year. Please take a few minutes and join us for this conversation.
An anniversary is a time for reflection on our history, the goals we’ve accomplished, the challenges we’ve surmounted, and the lessons we’ve learned along the way. Our video, “Catalyst of Hope and Health,” reflects on CSR’s work over the past 75 years to ensure that grant applications sent to NIH receive fair, independent, expert, and timely scientific reviews that are free from inappropriate influences, so NIH can fund the most promising research. Since its establishment, CSR has also sought to continually improve.
Twice since the onset of the public health emergency we have taken a look at the number of research applications submitted together with some demographic information on the affiliated scientists. We are continuing to follow this analysis again here, focusing on NIH R01-equivalent and RPG application patterns during April 9 and August 8 over the past five years.
There has been a lot of focus on early stage investigator (ESI) extension requests in the community recently. And we certainly understand why. The experience of the COVID-19 public health emergency has brought into sharp focus that the effects of the pandemic on careers and life in general may continue for years to come. This fact has led us to revisit our approach to granting ESI extension requests.
A cautionary tale about a breach of review integrity in the guise of a normal professional interaction.
Our modernized RePORTER site features a new application programming interface (API) that makes it easier to find, access, and reuse the grants data you need.
Take a few minutes and join us for this NIH All About Grants podcast mini-series on Early Stage Investigators (ESIs). In part 1 of this two-part conversation, we touch on NIH’s interest in supporting ESIs, who is and is not an ESI, the benefits afforded to ESIs, and more. We discuss extending one’s ESI status in part 2.
Since launching in 2017, NIH’s Next Generation Researchers Initiative (NGRI) is continuing to address longstanding challenges faced by researchers trying to embark upon and sustain independent research careers as well as to promote the stability and diversity of the biomedical research workforce. Today, we are sharing data on our progress towards increased support for ESIs and other targeted groups.
NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2020 actual spending data and estimates for FY 2021 and 2022. “Coronaviruses” is a new category as part of this update.